[HT-10-1] 球脊髄性筋萎縮症における神経筋変性の分子メカニズム
A recent advance in understanding the pathogenesis of various motor neuron diseases has lead to groundbreaking therapies for motor neuron diseases, including spinobulbar muscular atrophy and spinal muscular atrophy. In ALS, the antisense oligonucleotide therapy and high thruput drug screening using iPS attract huge attention as a promising therapy. This symposium is focussing on therapeutic advances based on the recent innovative translational researches.
2007: M.D., Niigata University School of Medicine
2007-2008: Junior Resident in Internal Medicine, Anjo-kosei hospital
2014: Ph.D. (Doctor of Medical Science), Nagoya University Graduate School of Medicine, Department of Neurology
2017-present: Japan society for the promotion of science (JSPS)-Research Fellowship for Young Scientists (RPD)
抄録パスワード認証
パスワードは抄録集・参加証に記載してあります。